Tony Kirby explains why we should provide full care to all people arriving with resistant tuberculosis
It was hoped that extensively drug-resistant tuberculosis (XDR-TB) might never arrive on Australia’s shores. But new cases raise the spectre of death for patients, transmission to others and large costs for Australian taxpayers. Papua New Guinea (PNG) national Catherina Abraham, aged 20 years, “made it” to Australia and hit the headlines in October 2012 because she had been diagnosed with XDR-TB.1 After almost a year in an isolation ward at Cairns Base Hospital, she died on 8 March 2013. Her treatment cost Queensland Health about $500 000 and would have cost $1 million had she lived to complete it.1 Now another PNG national has been diagnosed with XDR-TB in Australia. In the preceding 8 years, only two other XDR-TB cases were recorded in Australia.2
- 1. Rise of the superbugs. Four Corners [television program]. Australian Broadcasting Corporation, 2012; 29 Oct. http://www.abc.net.au/4corners/stories/2012/10/25/3618608.htm (accessed Jan 2012).
- 2. Johnson PDR. Extensively resistant tuberculosis in the lands Down Under [editorial]. Med J Aust 2011; 194: 565-566. <MJA full text>
- 3. Health Protection Agency (UK). Tuberculosis in the UK: 2012 report. http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1317134913404 (accessed Jan 2013).
- 4. McBryde E. Evaluation of risks of tuberculosis in Western Province Papua New Guinea. http://www.ausaid.gov.au/countries/pacific/png/Documents/png-tb-evaluation-of-risk.pdf (accessed Feb 2012).
- 5. National Tuberculosis Advisory Committee. The strategic plan for control of tuberculosis in Australia: 2011–2015. Commun Dis Intell 2012; 36: E286-E293.
- 6. Reynolds PN, Turnidge JD, Gottlieb T, Moore MJ; Thoracic Society of Australia and New Zealand; Australian Society for Microbiology; Australasian Society for Infectious Diseases; Public Health Association of Australia. Cross-border patients with tuberculosis [position statement]. Med J Aust 2011; 195: 523-524. <MJA full text>
Publication of your online response is subject to the Medical Journal of Australia's editorial discretion. You will be notified by email within five working days should your response be accepted.